These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 18822689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH, Hyun MS, Kim JR.
    Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
    [Abstract] [Full Text] [Related]

  • 4. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
    Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Lee HJ, Eun JY, Kim HG, Yoon SS, Lee DS, Kim JH, Kim JR.
    Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
    [Abstract] [Full Text] [Related]

  • 5. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
    De Lédinghen V, Monvoisin A, Neaud V, Krisa S, Payrastre B, Bedin C, Desmoulière A, Bioulac-Sage P, Rosenbaum J.
    Int J Oncol; 2001 Jul; 19(1):83-8. PubMed ID: 11408926
    [Abstract] [Full Text] [Related]

  • 6. Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.
    Lee KH, Kim JR.
    Exp Mol Med; 2009 Mar 31; 41(3):180-8. PubMed ID: 19293637
    [Abstract] [Full Text] [Related]

  • 7. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM, Roztocil E, Davies MG.
    J Vasc Surg; 2005 Apr 31; 41(4):672-81. PubMed ID: 15874933
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
    Simon C, Goepfert H, Boyd D.
    Cancer Res; 1998 Mar 15; 58(6):1135-9. PubMed ID: 9515796
    [Abstract] [Full Text] [Related]

  • 9. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
    Han YC, Zeng XX, Wang R, Zhao Y, Li BL, Song M.
    Ai Zheng; 2007 Jan 15; 26(1):48-53. PubMed ID: 17222367
    [Abstract] [Full Text] [Related]

  • 10. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion.
    Simon C, Juarez J, Nicolson GL, Boyd D.
    Cancer Res; 1996 Dec 01; 56(23):5369-74. PubMed ID: 8968087
    [Abstract] [Full Text] [Related]

  • 11. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
    Wu R, Duan L, Ye L, Wang H, Yang X, Zhang Y, Chen X, Zhang Y, Weng Y, Luo J, Tang M, Shi Q, He T, Zhou L.
    Int J Oncol; 2013 Mar 01; 42(3):1001-10. PubMed ID: 23354417
    [Abstract] [Full Text] [Related]

  • 12. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 01; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W.
    Cancer Lett; 2006 Jul 28; 239(1):27-35. PubMed ID: 16169661
    [Abstract] [Full Text] [Related]

  • 15. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
    Ried S, Jäger C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, Lengyel E.
    J Biol Chem; 1999 Jun 04; 274(23):16377-86. PubMed ID: 10347197
    [Abstract] [Full Text] [Related]

  • 16. ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line.
    Juretic N, Santibáñez JF, Hurtado C, Martínez J.
    J Cell Biochem; 1999 Jun 04; 83(1):92-8. PubMed ID: 11500957
    [Abstract] [Full Text] [Related]

  • 17. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Jun 04; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 18. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration.
    Jo M, Thomas KS, Somlyo AV, Somlyo AP, Gonias SL.
    J Biol Chem; 2002 Apr 05; 277(14):12479-85. PubMed ID: 11805108
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells.
    Tacchini L, Dansi P, Matteucci E, Desiderio MA.
    Carcinogenesis; 2001 Sep 05; 22(9):1363-71. PubMed ID: 11532856
    [Abstract] [Full Text] [Related]

  • 20. Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation.
    Kondo A, Hirayama N, Sugito Y, Shono M, Tanaka T, Kitamura N.
    J Biol Chem; 2008 Jan 18; 283(3):1428-1436. PubMed ID: 18003605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.